Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

Immunotherapy, cancer treatments that alter the immune system, making it better apt to fight tumor cells, have provided novel and efficacious therapeutic options for patients with advanced, ...

Results from a groundbreaking clinical trial could soon change the way certain types of cancers are treated. A study published Sunday in the New England Journal of Medicine found that immunotherapy ...

Giving immunotherapy earlier in the day can significantly extend patients' survival, compared to giving treatment later in the day, a new study of lung cancer shows.

Published today in Clinical Cancer Research, findings from a study led by investigators at the Vall d'Hebron Institute of ...

Cancer care has long focused on what drugs to give and in what doses, but a growing body of evidence suggests the clock on the wall may be just as important. Researchers are finding that the hour a ...

Researchers demonstrated that newly developed molecules designed to block an immune checkpoint can trigger a powerful immune response against tumors. Scientists at MIT and Stanford University have ...

According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at ...

KSHB 41 reporter Elyse Schoenig covers the cities of Shawnee and Mission. She also focuses on issues surrounding the cost of health care, saving for retirement and personal debt. Share your story idea ...

Former Senator Ben Sasse announced his stage 4 pancreatic cancer diagnosis in 2025, calling it "a death sentence" while ...

Jon Desjardins, far left, is happy to be around for his family, thanks to successful treatment with immunotherapy after surgery for colorectal cancer. He joined a clinical trial led by Dr. Yelena ...